Who was studied, and how
Five numbers in the abstract
Where each one falls
Where it lands on the map
1,106people with type 2 diabetes, in this paper
Already taking metformin use, or nottheir own situation, not assigned
on metformin use
not on metformin use
Metformin use went with lower overall survival−47%
correlation, not a testAlready taking proper glycemic control, or nottheir own situation, not assigned
on proper glycemic control
improper glycemic control
Proper glycemic control went with lower overall survival−51%
correlation, not a testthe abstract, start to end
Both the use of metformin (HR 0.53, p < 0.0001 and HR 0.57, p = 0.017, respectively) and proper glycemic control (HR 0.49, p < 0.0001 and HR 0.40, p = 0.002, respectively) were …
… that both the use of metformin (HR 0.57 [95 % CI 0.36-0.90]; p = 0.017) …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
Overall survival (OS)metformin use vs no metformin use, in all patients
HR 0.53
Overall survival (OS)metformin use vs no metformin use, in diabetic patients
HR 0.57
Overall survival (OS)proper glycemic control vs improper glycemic control, in all patients
HR 0.49
Overall survival (OS)proper glycemic control vs improper glycemic control, in diabetic patients
HR 0.40
Glycemic control
HR 0.570.36–0.90
MetforminGlycemic controlAll-cause mortality
1 / 4